{
    "organizations": [],
    "uuid": "bf1298a00f3a76d684ccf79e8f632a98eaa305e8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/biocon-results/indias-biocon-q3-profit-plunges-46-pct-idUSL4N1PJ4BT",
    "ord_in_thread": 0,
    "title": "India's Biocon Q3 profit plunges 46 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Biocon Ltd, Indiaâ€™s biggest biotechnology firm, posted a 46 percent fall in third-quarter profit on Wednesday hurt by an increase in interest and depreciation costs related to its Malaysia operations.\nProfit fell to 919 million rupees ($14.43 million) in the quarter ended Dec. 31, compared with 1.71 billion rupees a year earlier. bit.ly/2rvTd8e\nRevenue from operations rose 1.3 percent to 10.58 billion rupees. ($1 = 63.6900 Indian rupees) (Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Supriya Kurane)\n ",
    "published": "2018-01-24T21:08:00.000+02:00",
    "crawled": "2018-01-25T13:04:01.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "biocon",
        "ltd",
        "india",
        "biggest",
        "biotechnology",
        "firm",
        "posted",
        "percent",
        "fall",
        "profit",
        "wednesday",
        "hurt",
        "increase",
        "interest",
        "depreciation",
        "cost",
        "related",
        "malaysia",
        "operation",
        "profit",
        "fell",
        "million",
        "rupee",
        "million",
        "quarter",
        "ended",
        "compared",
        "billion",
        "rupee",
        "year",
        "earlier",
        "revenue",
        "operation",
        "rose",
        "percent",
        "billion",
        "rupee",
        "indian",
        "rupee",
        "reporting",
        "jessica",
        "kuruthukulangara",
        "bengaluru",
        "editing",
        "supriya",
        "kurane"
    ]
}